Linear IgA Bullous Dermatosis (LABD)

Figure 3.27 A: Cicatricial pemphigoid (Courtesy of Dr. Iris K. Aronson) B: Cicatricial pemphigoid (Courtesy of Dr. Iris K. Aronson) C: LABD, DIF (Courtesy of Dr. Lawrence Chan)
Figure 3.27
A: Cicatricial pemphigoid
(Courtesy of Dr. Iris K.
Aronson
)
B: Cicatricial pemphigoid
(Courtesy of Dr. Iris K.
Aronson
)
C: LABD, DIF
(Courtesy of Dr. Lawrence
Chan
)
(Figure 3.27C)
  • Rare, subepidermal blistering disease with IgA deposition at BMZ; likely identical to chronic bullous disease of childhood (CBDC)
  • Autoantigen: LAD-1 (120 kDa, part of BPAG2); LAD-1 cleavage results in second autoantigen, LABD97 (97 kDa)
  • Clinical: annular or grouped vesicles/bullae over extensor extremities and buttock typically in herpetic arrangement; mucosal involvement
  • Drug-induced: vancomycin (most common), captopril, cephalosporin, PCN, NSAIDs, phenytoin, sulfonamide
  • Histology: subepidermal bullae with rich neutrophilic infiltrate in papillary dermis (may resemble DH)
  • DIF: linear IgA (± C3) deposition at BMZ
  • IIF: + in 60% cases, IIF on (SSS) shows binding to epidermal side of split (roof)
  • Treatment: dapsone or sulfapyridine, low dose oral corticosteroid